Related Experiment Video
Updated: Apr 30, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims
Taisuke Kojima1, Satoshi Osaga2, Toshihiko Aranishi3
1Japan Drug Development & Medical Affairs, Eli Lilly, Japan.
Aim:
This study aimed to estimate the medical costs attributable to obesity among Japanese adults with obesity-related health disorders using the JMDC claims database and assess the impact of body mass index (BMI) categories on the medical costs during a five-year follow-up period.
Materials And Methods:
A retrospective cohort study using anonymized claims and health checkup data from the JMDC database was conducted. Participants aged ≥18 years with first recorded BMI between December 2012 and December 2018 and diagnosed with obesity-related health disorders were included. Participants were stratified into two groups: those without obesity (BMI <25.0 kg/m2) and those with obesity (BMI ≥25.0 kg/m2). Annual medical costs (total, outpatient, inpatient, medication) were summarized. Generalized estimating equations (GEE) with a gamma regression model and log link function were used to estimate cost ratios and adjusted mean total medical costs, adjusting for age category, sex, baseline BMI category, and baseline outpatient visit frequency. Sensitivity analyses were performed to assess robustness across different age groups and regression models.
Results:
A total of 244,150 eligible participants were analyzed (without obesity: 150,217; with obesity: 93,933). Over five-year follow-up, total medical costs per person-year increased from 218,929 to 265,919 JPY in those without obesity and from 234,093 to 323,086 JPY in those with obesity. Higher baseline BMI showed greater five-year increases in the adjusted medical costs, resulting in 27.7% increase by excess costs due to obesity with 83.3% of those attributable to BMI ≥27.0 kg/m2. Sensitivity analyses confirmed the robustness of these findings.
Conclusions:
The estimated excess costs due to obesity indicate higher healthcare costs among Japanese adults with obesity-related health disorders. The per capita burden appeared higher in those with higher BMI, with most excess costs concentrated in individuals with BMI ≥27.0 kg/m2. These results highlight the healthcare cost burden associated with obesity and suggest that effective weight management strategies may contribute to reducing healthcare expenditures.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Preventive Healthcare Services
Bias in Epidemiological Studies